VibroSense Dynamics is preparing for launch – has started cooperating with Retailer

As a step in the preparation for launching VibroSense Meter ® II, the combined hand- and foot-instrument, VibroSense Dynamics AB has started to cooperate with two retailers. These retailers are active in the UK, the Benelux countries and Germany.

VibroSense Dynamics has initiated a cooperation with two retailers as a part of the plan to launch the Vibrosense Meter® II. The retailers are MedCaT ( http://www.medcat.nl/EU/ ) active on the German and the Benelux markets and MediMax Global ( http://www.medimaxglobaluk.com/ ) active on the British market. Both companies have a long history of selling medtech products to the target customers for the VibroSense Meter® II which are for example clinics in neurophysiology, oncology and diabetes.

VibroSense Dynamics has not yet signed formal retailer agreements since the purpose of the cooperation is to evaluate these retailers’ ability to sell the VibroSense products and services.

-           These retailers are potentially very good partners for VibroSense since they do not only have a long experience in selling similar medtech products but they also have a strong network of customers and partners potentially interested in the VibroSense products and services, says Ulf Rogers, Sales- and Marketing Director, VibroSense Dynamics AB.

Toni Speidel, CEO VibroSense Dynamics AB,
Tel: +46 40 650 14 12
E-mail: info@vibrosense.com
www.vibrosense.com

This information is information that VibroSense Dynamics AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on October 6th 2017.

VibroSense Dynamics AB (public) develops and markets efficient systems for early detection and diagnosis of peripheral sensory neuropathy, i.e. disease of large nerve fibres and nerve trunks in the legs and arms. The Company, founded in 2005, has been listed on AktieTorget since May 2015.

About Us

VibroSense Dynamics AB (public) develops and markets efficient systems for early detection and diagnosis of peripheral sensory neuropathy, i.e. disease of large nerve fibers and nerve trunks in the legs and arms. The Company, founded in 2005, is listed on the Small Cap list AktieTorget since May 2015. The product portfolio includes a CE-marked medical device, the VibroSense Meter, for diagnostics of impaired sensitivity in the hands. www.vibrosense.com

Subscribe

Documents & Links